Contract Win

Angle PLC
20 July 2005


For Immediate Release                                             20 July 2005

                                   ANGLE plc

            Wins Contract With The BioBusiness Alliance of Minnesota

ANGLE plc, the venture management and consulting company specialising in the
commercialisation of technology and the development of technology-based industry
is pleased to announce that its US Consulting and Management division has won a
contract with The BioBusiness Alliance of Minnesota, worth $200,000, to conduct
a comprehensive assessment of the state's biobusiness capabilities.

The BioBusiness Alliance of Minnesota is an industry-driven, business
development organisation of representatives from established and emerging
Minnesota companies, universities and government. It is devoted to building the
bioscience industry, retaining and creating jobs and economic growth, and
positioning Minnesota as a global leader in biobusiness. The Minnesota
biobusiness industry includes many World-class businesses and institutions such
Medtronic, 3M and the Mayo Clinic.

The information from the six month assessment, which will conclude in the fourth
quarter of 2005, will benchmark Minnesota against other countries and states.
The outcome of the process will identify the State's strengths and development
needs, and provide recommendations to target specific areas of biobusiness in
which Minnesota can compete as a global leader. These recommendations will
reflect the convergence of technologies, products, and markets that exist in the
State, and identify Minnesota's opportunity areas for growth.

ANGLE established a Minnesota office in August 2004 in recognition of the
significant business potential it believes exists in this State. ANGLE was
chosen following a rigorous national and international selection process. ANGLE
was selected for their significant experience both in conducting assessments in
the U.S. and internationally, and for their consulting expertise in the
technology industry.

Dr. Gary P. Evans, CEO of ANGLE's US Operations, said:

'We are delighted that ANGLE has been selected to deliver this innovative,
industry-driven assessment of Minnesota's biobusiness capabilities. We look
forward to working with the BioBusiness Alliance team to take the first step in
the long-term planning and development of a biobusiness strategy for Minnesota.'

Andrew Newland, Chief Executive of ANGLE plc, said:

'This contract is a great example of ANGLE's continuing expansion within the
United States. The Minnesota region is a prosperous biobusiness arena and this
contract will position ANGLE alongside some of the biggest names in the market.
We expect that Minnesota will emerge as a further key platform for our Ventures
business in the US.'

                                    - ENDS -





For further information

ANGLE plc
Andrew Newland, Chief Executive                       Tel: [phone]
Lisa Smith, Principal Executive, US Operations        Tel: [phone]

Buchanan Communications                               Tel: [phone]
Richard Darby, Suzanne Brocks, James Strong

Notes to Editors
Founded in 1994, ANGLE is an international venture management and consulting
company focusing on the commercialisation of technology and the development of
technology-based industry. ANGLE creates, develops and advises technology
businesses on its own behalf and for its clients. This includes extensive
expertise in the commercialization of technology, new company formation,
investment and corporate finance, Research Park and incubator development and
management, and delivery of economic development programs. ANGLE operates from
offices in the UK, the US and the Middle East.

ANGLE is listed on AIM (AGL.L); further information can be found on
www.ANGLEplc.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange